In CIP patients, gamma globulin/albumin and glucocorticoids usage was significantly higher than in No CIP (39.4% vs 23.3%, p=0.007; 79.8% vs 12.8%, p<0.0001). This evidence concerns the gene ALB and hereditary sensory and autonomic neuropathy.